flumazenil has been researched along with Prostatic Hyperplasia in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birch, BR | 1 |
| Gelister, JS | 1 |
| Parker, CJ | 1 |
| Chave, H | 1 |
| Miller, RA | 1 |
1 other study available for flumazenil and Prostatic Hyperplasia
| Article | Year |
|---|---|
Transurethral resection of prostate under sedation and local anesthesia (sedoanalgesia). Experience in 100 patients.
Topics: Aged; Anesthesia, Local; Conscious Sedation; Flumazenil; Humans; Lidocaine; Male; Midazolam; Prostat | 1991 |